Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review
Authors
Keywords
-
Journal
PHARMACOECONOMICS
Volume 36, Issue 3, Pages 301-322
Publisher
Springer Nature
Online
2017-12-09
DOI
10.1007/s40273-017-0595-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)
- (2016) Lazaros Andronis et al. BJU INTERNATIONAL
- TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer
- (2016) Nicholas James et al. HEALTH TECHNOLOGY ASSESSMENT
- Economic evaluation of single-fraction versus multiple-fraction palliative radiotherapy for painful bone metastases in breast, lung and prostate cancer
- (2016) Lucie Collinson et al. Journal of Medical Imaging and Radiation Oncology
- Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both
- (2016) Nicholas D. James et al. JAMA Oncology
- Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
- (2016) Jipan Xie et al. JOURNAL OF MANAGED CARE PHARMACY
- Interpretation of the Expected Value of Perfect Information and Research Recommendations
- (2015) Joanna Thorn et al. MEDICAL DECISION MAKING
- A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research
- (2015) Lazaros Andronis et al. MEDICAL DECISION MAKING
- Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample
- (2015) Mark Strong et al. MEDICAL DECISION MAKING
- Analytic approaches for research priority-setting: issues, challenges and the way forward
- (2015) Lazaros Andronis Expert Review of Pharmacoeconomics & Outcomes Research
- A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?
- (2015) Khachapon Nimdet et al. PLoS One
- Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
- (2014) J Ford et al. HEALTH TECHNOLOGY ASSESSMENT
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Practical Guide to Value of Information Analysis
- (2014) Edward C. F. Wilson PHARMACOECONOMICS
- Value of Information Analysis in Oncology: The Value of Evidence and Evidence of Value
- (2014) Haitham W. Tuffaha et al. Journal of Oncology Practice
- Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
- (2012) Jipan Xie et al. Clinical Breast Cancer
- Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast Cancer
- (2012) Sonya J. Snedecor et al. CLINICAL THERAPEUTICS
- THE EFFECT OF ENGLISH-LANGUAGE RESTRICTION ON SYSTEMATIC REVIEW-BASED META-ANALYSES: A SYSTEMATIC REVIEW OF EMPIRICAL STUDIES
- (2012) Andra Morrison et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
- (2012) Joshua A Salomon et al. LANCET
- A Systematic and Critical Review of the Evolving Methods and Applications of Value of Information in Academia and Practice
- (2012) Lotte Steuten et al. PHARMACOECONOMICS
- Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
- (2012) J. Jaime Caro et al. VALUE IN HEALTH
- Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
- (2012) Alison Stopeck et al. JOURNAL OF MEDICAL ECONOMICS
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A cost-effectiveness analysis
- (2012) Sonya J. Snedecor et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness of Zoledronic Acid in the Management of Skeletal Metastases in Patients With Lung Cancer in France, Germany, Portugal, The Netherlands, and the United Kingdom
- (2011) Avani D. Joshi et al. CLINICAL THERAPEUTICS
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Using QALYs in Cancer
- (2011) Martina Garau et al. PHARMACOECONOMICS
- Cost effectiveness of zoledronic acid in the management of skeletal metastases in hormone-refractory prostate cancer patients in France, Germany, Portugal, and the Netherlands
- (2011) J.A. Carter et al. JOURNAL OF MEDICAL ECONOMICS
- Dangerous omissions: the consequences of ignoring decision uncertainty
- (2010) Susan C. Griffin et al. HEALTH ECONOMICS
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure
- (2009) Jean-Jacques Body et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started